Dr. Boeder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4168 Front St
San Diego, CA 92103Phone+1 619-543-6303Fax+1 619-543-7277
Summary
- Dr. Schafer Boeder is an endocrinologist based in San Diego, CA, specializing in diabetes and metabolism. He completed his fellowship in Endocrinology, Diabetes, and Metabolism at the University of California (San Diego) Medical Center in 2017, following his internal medicine residency at the same institution. Dr. Boeder graduated from Eastern Virginia Medical School in 2012. His recent publications focus on diabetes-related research, including work on kidney function in diabetes, combination therapies for Type 1 diabetes, and continuous glucose monitoring. His studies have been published in prominent journals such as the Journal of the American Society of Nephrology and Diabetes Care.
Education & Training
University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2012 - 2015
Eastern Virginia Medical SchoolClass of 2012
Certifications & Licensure
CA State Medical License 2014 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 5 citationsCombination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial.Schafer C Boeder, Robert L Thomas, Melissa J Le Roux, Erin R Giovannetti, Justin M Gregory
Diabetes Care. 2025-01-01 - 1 citationsAcetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1.Charles Ginsberg, Jesse C Seegmiller, Volker Vallon, Sami SeungMi Jin, Robert L Thomas
Journal of the American Society of Nephrology. 2024-10-08 - 3 citationsBeta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin.Schafer Boeder, Michael J Davies, Janet B McGill, Richard Pratley, Manon Girard
Diabetes Technology & Therapeutics. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
